These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15281003)

  • 41. Distribution of PAF-acetylhydrolase activity in human plasma low-density lipoprotein subfractions.
    Karabina SA; Liapikos TA; Grekas G; Goudevenos J; Tselepis AD
    Biochim Biophys Acta; 1994 Jun; 1213(1):34-8. PubMed ID: 8011677
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Associations of LDL size with in vitro oxidizability and plasma levels of in vivo oxidized LDL in Type 2 diabetic patients.
    Scheffer PG; Bos G; Volwater HG; Dekker JM; Heine RJ; Teerlink T
    Diabet Med; 2003 Jul; 20(7):563-7. PubMed ID: 12823238
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antioxidant supplementation effects on low-density lipoprotein oxidation for individuals with type 2 diabetes mellitus.
    Anderson JW; Gowri MS; Turner J; Nichols L; Diwadkar VA; Chow CK; Oeltgen PR
    J Am Coll Nutr; 1999 Oct; 18(5):451-61. PubMed ID: 10511327
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility.
    McCall MR; La Belle M; Forte TM; Krauss RM; Takanami Y; Tribble DL
    Biochim Biophys Acta; 1999 Jan; 1437(1):23-36. PubMed ID: 9931415
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lower susceptibility of low density lipoprotein to in vitro oxidation in diabetic patients.
    Taus M; Ferretti G; Curatola G; Dousset N; Solèra ML; Valdiguie P
    Biochem Int; 1992 Dec; 28(5):835-42. PubMed ID: 1288493
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants.
    Mäkimattila S; Liu ML; Vakkilainen J; Schlenzka A; Lahdenperä S; Syvänne M; Mäntysaari M; Summanen P; Bergholm R; Taskinen MR; Yki-Järvinen H
    Diabetes Care; 1999 Jun; 22(6):973-81. PubMed ID: 10372251
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased oxidizability of plasma lipoproteins in diabetic patients can be decreased by probucol therapy and is not due to glycation.
    Babiy AV; Gebicki JM; Sullivan DR; Willey K
    Biochem Pharmacol; 1992 Mar; 43(5):995-1000. PubMed ID: 1554398
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lipoprotein compositional abnormalities in type 1 (insulin-dependent) diabetic patients.
    Manzato E; Zambon A; Zambon S; Nosadini R; Doria A; Marin R; Crepaldi G
    Acta Diabetol; 1993; 30(1):11-6. PubMed ID: 8329725
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Low density lipoprotein rich in triglycerides and hepatic lipase activity in insulin-dependent diabetic patients].
    Rosental SB; Schreier LE; Halperin H; Berg G; Paglione AM; Ruiz M; Wikinski RL
    Medicina (B Aires); 1995; 55(4):317-23. PubMed ID: 8728871
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lipoprotein composition in NIDDM: effects of dietary oleic acid on the composition, oxidisability and function of low and high density lipoproteins.
    Dimitriadis E; Griffin M; Collins P; Johnson A; Owens D; Tomkin GH
    Diabetologia; 1996 Jun; 39(6):667-76. PubMed ID: 8781762
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glycation and oxidation of human low density lipoproteins reduces heparin binding and modifies charge.
    Gugliucci Creriche A; Stahl AJ
    Scand J Clin Lab Invest; 1993 Apr; 53(2):125-32. PubMed ID: 8469911
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glucose influence on copper ion-dependent oxidation of low density lipoprotein.
    Ghaffari MA; Mojab S
    Iran Biomed J; 2009 Jan; 13(1):59-64. PubMed ID: 19252679
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of antioxidant activity in lipoprotein fractions from insulin-dependent diabetics and healthy controls.
    Maxwell S; Holm G; Bondjers G; Wiklund O
    Atherosclerosis; 1997 Feb; 129(1):89-96. PubMed ID: 9069522
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia.
    Nobécourt E; Jacqueminet S; Hansel B; Chantepie S; Grimaldi A; Chapman MJ; Kontush A
    Diabetologia; 2005 Mar; 48(3):529-38. PubMed ID: 15729582
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of lipid-lowering therapy on low-density lipoprotein auto-antibodies: relationship with low-density lipoprotein oxidation and plasma total antioxidant status.
    Orem C; Orem A; Uydu HA; Celik S; Erdöl C; Kural BV
    Coron Artery Dis; 2002 Feb; 13(1):65-71. PubMed ID: 11917201
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of young barley leaf extract and antioxidative vitamins on LDL oxidation and free radical scavenging activities in type 2 diabetes.
    Yu YM; Chang WC; Chang CT; Hsieh CL; Tsai CE
    Diabetes Metab; 2002 Apr; 28(2):107-14. PubMed ID: 11976562
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of LDL+VLDL oxidizability and hyperglycemia on blood cholesterol, phospholipid and triglyceride levels in type-I diabetic patients.
    Jain SK; McVie R; Meachum ZD; Smith T
    Atherosclerosis; 2000 Mar; 149(1):69-73. PubMed ID: 10704616
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes.
    Colhoun HM; Otvos JD; Rubens MB; Taskinen MR; Underwood SR; Fuller JH
    Diabetes; 2002 Jun; 51(6):1949-56. PubMed ID: 12031985
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oxidizability of atherogenic low-density lipoprotein subspecies in severe familial hypercholesterolemia: impact of long-term low-density lipoprotein apheresis.
    Lepage S; Nigon F; Bonnefont-Rousselot D; Assogba U; Goulinet S; Chancharme L; Delattre J; Bruckert E; Chapman MJ
    J Cardiovasc Pharmacol Ther; 2000 Apr; 5(2):87-103. PubMed ID: 11150388
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of fast-food Mediterranean-type diet on human plasma oxidation.
    Aronis P; Antonopoulou S; Karantonis HC; Phenekos C; Tsoukatos DC
    J Med Food; 2007 Sep; 10(3):511-20. PubMed ID: 17887946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.